Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Stallergenes Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (72)
Cancellation by sponsor (47)
Prescription medicine registration (2)
Australian Public Assessment Report (AusPAR) (1)

Date

2024 (1)
2022 (2)
2021 (45)
2017 (1)
2016 (2)
2015 (2)
2011 (2)
2010 (2)
2008 (1)
2006 (10)
1991 (54)

Results for "[search-keyword]"

Search

Sponsor content

122 result(s) found, displaying 41 to 50

ALUSTAL RYE GRASS EXTRACT lolium perenne injection suspension vial composite pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Stallergenes Australia Pty Ltd
ALUSTAL RYE GRASS EXTRACT lolium perenne 10 IR/mL injection suspension vial Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Stallergenes Australia Pty Ltd
ALUSTAL PLANTAIN POLLEN EXTRACT plantago lanceolata injection suspension vial composite pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Stallergenes Australia Pty Ltd
ALUSTAL PLANTAIN POLLEN EXTRACT plantago lanceolata 10 IC/mL injection suspension vial Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Stallergenes Australia Pty Ltd
ALUSTAL BERMUDA GRASS EXTRACT cynodon dactylon injection suspension vial composite pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Stallergenes Australia Pty Ltd
ALUSTAL BERMUDA GRASS EXTRACT cynodon dactylon 10 IR/mL injection suspension vial Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Stallergenes Australia Pty Ltd
ALUSTAL EXTRACT OF TWELVE GRASSES injection suspension vial composite pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Stallergenes Australia Pty Ltd
ALUSTAL EXTRACT OF TWELVE GRASSES 10 IR/mL injection suspension vial Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Stallergenes Australia Pty Ltd
ACTAIR Initiation Treatment 100IR & 300IR sublingual tablets blister pack (233470)

15 April 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ACTAIR Initiation Treatment 100IR & 300IR sublingual tablets blister pack.
ACTAIR Continuation Treatment 300IR sublingual tablets blister pack (233471)

15 April 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ACTAIR Continuation Treatment 300IR sublingual tablets blister pack.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.